January 05, 2026 (MLN): Liven Pharma Limited (PSX: LIVEN) is engaged in preliminary discussions with Hoover Pharma (Private) Limited regarding a potential acquisition.

The talks remain at an early, exploratory stage, with both sides assessing the viability and feasibility of a possible transaction.

No final decision has been taken so far, and the discussions are focused on evaluating strategic fit and potential benefits, according to the on PSX revealed today.

Any potential transaction would remain subject to further evaluation, regulatory clearances, and the outcome of detailed due diligence.

The ongoing deliberations do not represent a definitive agreement or commitment at this point.

The disclosure aims to maintain transparency for the market and stakeholders as discussions continue.

Copyright